3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Melanoma
1
Hepatitis
1
Colitis
1
Interventions
pembrolizumab
303
Carboplatin
232
Cisplatin
161
Paclitaxel
154
Gemcitabine
153
Pemetrexed
123
Bevacizumab
121
Docetaxel
106
durvalumab
83
Oxaliplatin
82
Nivolumab
82
Dexamethasone
80
atezolizumab
79
Fluorouracil
79
Cyclophosphamide
79
130-nm albumin-bound paclitaxel
74
Fulvestrant
72
Capecitabine
67
Injections
66
Cetuximab
64
Leucovorin
63
Rituximab
57
fludarabine
53
Lenalidomide
51
venetoclax
47
Prednisone
45
Letrozole
42
Irinotecan
42
enzalutamide
41
tislelizumab
38
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
vedolizumab
×
90 days
×
Clear all
NCT07619898
2026-06-02
PHOENIX-ECP
Therakos LLC
Phase 2
Not yet recruiting
112 enrolled